- Home
- MPX vs ATAI Comparison
MPX vs ATAI Comparison
Compare MPX & ATAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MPX
- ATAI
- Stock Information
- Founded
- MPX 1965
- ATAI 2018
- Country
- MPX United States
- ATAI Germany
- Employees
- MPX N/A
- ATAI N/A
- Industry
- MPX Marine Transportation
- ATAI Biotechnology: Pharmaceutical Preparations
- Sector
- MPX Industrials
- ATAI Health Care
- Exchange
- MPX Nasdaq
- ATAI Nasdaq
- Market Cap
- MPX 326.0M
- ATAI 280.2M
- IPO Year
- MPX N/A
- ATAI 2021
- Fundamental
- Price
- MPX $8.57
- ATAI $1.99
- Analyst Decision
- MPX Hold
- ATAI Strong Buy
- Analyst Count
- MPX 1
- ATAI 4
- Target Price
- MPX $8.00
- ATAI $9.00
- AVG Volume (30 Days)
- MPX 38.0K
- ATAI 4.9M
- Earning Date
- MPX 01-30-2025
- ATAI 03-27-2025
- Dividend Yield
- MPX 6.52%
- ATAI N/A
- EPS Growth
- MPX N/A
- ATAI N/A
- EPS
- MPX 0.50
- ATAI N/A
- Revenue
- MPX $236,555,000.00
- ATAI $331,000.00
- Revenue This Year
- MPX $3.97
- ATAI $80.07
- Revenue Next Year
- MPX $13.02
- ATAI N/A
- P/E Ratio
- MPX $17.18
- ATAI N/A
- Revenue Growth
- MPX N/A
- ATAI N/A
- 52 Week Low
- MPX $8.54
- ATAI $1.03
- 52 Week High
- MPX $12.47
- ATAI $2.85
- Technical
- Relative Strength Index (RSI)
- MPX 38.31
- ATAI 51.96
- Support Level
- MPX $8.54
- ATAI $1.94
- Resistance Level
- MPX $9.04
- ATAI $2.16
- Average True Range (ATR)
- MPX 0.26
- ATAI 0.34
- MACD
- MPX -0.06
- ATAI -0.03
- Stochastic Oscillator
- MPX 2.38
- ATAI 48.38
About MPX Marine Products Corporation
Marine Products Corp is a manufacturer of fiberglass motorized boats distributed and marketed through its independent dealer network. The company's only operating segment is Powerboat Manufacturing Business. It operates in the Powerboat Manufacturing business segment through Nashville, Georgia, Valdosta, and Georgia. Its product offerings include Chaparral sterndrive, outboard pleasure boats and Robalo outboard sport fishing boats. The company offers its products to the family recreational markets through its Chaparral brand and to the sportfishing market through its Robalo brand.
About ATAI ATAI Life Sciences N.V.
ATAI Life Sciences NV is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. Its product candidates include COMP360/Psilocybin therapy, PCN-101/R-ketamine, RL-007/Compound, DMX-1002/Ibogaine, GRX-917/Deuterated etifoxine, VLS-01/DMT, EMP-01/MDMA derivative, RLS-01/Salvinorin A, KUR-101/Deuterated Mitragynine, and DMX-1001/Noribogaine. The business operates geographically in two regions being the United States and Germany.